Which is it?Was financing the issue or not? If so, it must still be an issue as $25mil is deemed not enough?
Maybe financing was never the issue, so in that case, what is it? Does the market collectively doubt that they can get anything past the FDA? I thought they would have something to drive this higher and make the Shorts nervous before the Conference Call at month end? Time is getting short - time to "deliver".